These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 7909645

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pancreatitis and pancreatic necrosis during sulfasalazine therapy.
    Faintuch J, Mott CB, Machado MC.
    Int Surg; 1985; 70(3):271-2. PubMed ID: 2872181
    [Abstract] [Full Text] [Related]

  • 3. Fatal massive hepatic necrosis: a probable hypersensitivity reaction to sulfasalazine.
    Ribe J, Benkov KJ, Thung SN, Shen SC, LeLeiko NS.
    Am J Gastroenterol; 1986 Mar; 81(3):205-8. PubMed ID: 2869683
    [Abstract] [Full Text] [Related]

  • 4. Sulfasalazine-induced agranulocytosis.
    Jacobson IM, Kelsey PB, Blyden GT, Demirjian ZN, Isselbacher KJ.
    Am J Gastroenterol; 1985 Feb; 80(2):118-21. PubMed ID: 2857524
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fulminant hepatic failure, hepatorenal syndrome, and necrotizing pancreatitis after minocycline hepatotoxicity.
    Boudreaux JP, Hayes DH, Mizrahi S, Hussey J, Regenstein F, Balart L.
    Transplant Proc; 1993 Apr; 25(2):1873. PubMed ID: 8470208
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative).
    Tameda Y, Hamada M, Takase K, Nakano T, Kosaka Y.
    Hepatology; 1996 Mar; 23(3):465-70. PubMed ID: 8617425
    [Abstract] [Full Text] [Related]

  • 9. [Hypersensitivity reaction to sulfasalazine with a clinical picture similar to mononucleosis].
    Foresti V, Tronci M, Ungaro A, Confalonieri F.
    Recenti Prog Med; 1988 Sep; 79(9):382-3. PubMed ID: 2904684
    [No Abstract] [Full Text] [Related]

  • 10. Pulmonary infiltrates and skin pigmentation associated with sulfasalazine.
    Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S, Matsumoto K, Kitagawa T, Yamamoto J.
    Am J Gastroenterol; 1992 Nov; 87(11):1654-7. PubMed ID: 1359782
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection.
    Coban S, Ceydilek B, Ekiz F, Erden E, Soykan I.
    Ann Pharmacother; 2005 Oct; 39(10):1737-40. PubMed ID: 16105873
    [Abstract] [Full Text] [Related]

  • 13. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H, Munakata A, Yoshida Y.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Surface necroses of the skin following sulfasalazine therapy in ulcerative colitis].
    Krakamp B, Beinhoff U, Knöpfle G, Leidig P.
    Med Klin (Munich); 1988 Sep 16; 83(18):611-2. PubMed ID: 2903432
    [No Abstract] [Full Text] [Related]

  • 16. [A case of acute pancreatitis induced by multiple drugs in a patient with ulcerative colitis].
    Son CN, Lee HL, Joo YW, Lee OY, Han DS, Yoon BC, Choi HS, Hahm JS.
    Korean J Gastroenterol; 2008 Sep 16; 52(3):192-5. PubMed ID: 19077517
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pancreatitis after rectal administration of 5-aminosalicylic acid.
    Isaacs KL, Murphy D.
    J Clin Gastroenterol; 1990 Apr 16; 12(2):198-9. PubMed ID: 1969872
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.